As LUSC and LUAD are the most common subtypes of NSCLC, we evaluated the diagnostic efficacy of anti-COPT1 autoantibodies in these two subtypes of NSCLC. This evidence concerns the gene SLC31A1 and non-small cell lung carcinoma.